Skip to main content

Home Ceinge EN

  • Forty years of CEINGE
    twenty years after the inauguration
    of the headquarters
    Yesterday, Today and Tomorrow of the Center for Molecular Biology and Advanced Biotechnology
  • New therapeutic perspectives
    for children with SMA
  • Sanfilippo syndrome,
    “molecular tweezers”
    Block Neurodegeneration

CEINGE - Biotecnologie Avanzate Franco Salvatore

CEINGE is a prestigious research center in the field of molecular biology and advanced biotechnology applied to Human Health. Founded in 1983 by Professor Francesco Salvatore, the center is a non-profit consortium company with entirely public capital, which includes among its members the Federico II University Hospital and the University of Naples.

Areas of expertise

CEINGE excels in molecular diagnostics and neonatal screening excels in molecular diagnostics and neonatal screening of hereditary diseases, advanced biotechnology research of hereditary diseases, advanced biotechnological research, training, scientific promotion, advanced oncology, training, scientific promotion, technological transfer and production of goods biotechnological.

Structure and headquarters

CEINGE operates in a building located in Naples, in via Gaetano Salvatore 486, with an area of ​​over 8,500 square meters. These spaces are equipped with the latest generation scientific equipment.

News

 ft credits@ceinge2024
Forty years of CEINGE twenty years after the inauguration of the headquarters

Il 17 aprile, alle ore 10.00, si è tenuta la cerimonia per il Quarantennale dalla fondazione e per il Ventennale della sede del CEINGE.

©CEINGE credits@CEINGE
Cells in 3D: a new technique from microscopy

An international study, led by Italian researchers from Istituto di scienze applicate e sistemi intelligenti “E.

fotocredits@ceinge
Cell division: a mechanism for chromosome segregation unveiled

The results of the study will help to better understand how cell duplicate and how alterations of this mechanism may cause diseases like cancer.

ft credits@ceinge
In Italy identified 5 variants of Sars-Cov2

Lo aiutano a replicarsi? Servono più dati per parlare di nuove mutazioni

fotocredits@ceinge
Antigenic and salivary tests for SARS COV2 infection: 50 percent and 30 percent reliable

Here is the report of the scientists

Nell’ambito del Progetto di ricerca Task-Force COVID-20 finanziato dalla Regione Campania, al CEINGE-Biotecnologie Avanzate sono state svolte, tra le altre, due attività:

Research

 

 

Our Mission

At CEINGE we are committed to exploring the mechanisms that regulate gene expression and their pathological alterations. Developing advanced diagnostic and therapeutic technologies. Promoting interdisciplinarity and the integration of information technology in research.

Transitional Research and Innovations

We encourage our researchers to explore the practical applications of their discoveries, promoting translational research and supporting entrepreneurial activities that operate in our fields of expertise.

Organizational model and collaborations

We operate in synergy with research institutions, acting as an attractor and incubator of talent in a unique interdisciplinary environment. Our organizational model facilitates virtuous relationships and mutually beneficial collaborations.